Consequently, in this investigation, we have elucidated for the first time a mechanism through which DML impedes the progression of PC by down-regulating H3K18la, subsequently diminishing the expression of the downstream oncogene MESP1. The gene discussed is MESP1; the disease is pachyonychia congenita.